Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthequity (HQY) Short term Debt (2019 - 2023)

Healthequity has reported Short term Debt over the past 5 years, most recently at $17.5 million for Q1 2023.

  • For Q1 2023, Short term Debt rose 100.0% year-over-year to $17.5 million; the TTM value through Jan 2023 reached $17.5 million, up 100.0%, while the annual FY2023 figure was $17.5 million, 100.0% up from the prior year.
  • Short term Debt for Q1 2023 was $17.5 million at Healthequity, up from $15.3 million in the prior quarter.
  • Over five years, Short term Debt peaked at $78.1 million in Q3 2021 and troughed at $6.6 million in Q4 2021.
  • A 5-year average of $36.4 million and a median of $35.2 million in 2019 define the central range for Short term Debt.
  • Biggest five-year swings in Short term Debt: crashed 89.5% in 2021 and later surged 133.32% in 2022.
  • Year by year, Short term Debt stood at $31.2 million in 2019, then surged by 100.0% to $62.5 million in 2020, then crashed by 89.5% to $6.6 million in 2021, then surged by 133.32% to $15.3 million in 2022, then rose by 14.28% to $17.5 million in 2023.
  • Business Quant data shows Short term Debt for HQY at $17.5 million in Q1 2023, $15.3 million in Q4 2022, and $13.1 million in Q3 2022.